Aptar Digital Health has entered into a partnership with Enable Injections, Inc. to provide a companion digital platform that will run alongside Enable’s enFuse® On‑Body Delivery System. The platform will guide patients and caregivers through the injection process, capture treatment data, and offer training modules, patient‑reported outcomes, and symptom tracking. By integrating digital support with a large‑volume biologic delivery device, Aptar expands its digital health footprint and creates a new recurring revenue stream that complements its existing drug‑delivery component business.
Continue reading for full analysis...